SenesTech Reports First Quarter 2025 Financial Results 40% Revenue Growth in Evolve™, Record Gross Profit Margins of 65%, and Continued Progress Toward Profitability
SURPRISE, Ariz., May 8, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the first quarter ended March 31, 2024.Q1 2025 Highlights Revenues increased 17% to 415,000 in Q1 2024. Evolve product sales grew 40% year-over-year, now representing 79% of total revenue. Gross profit margin expanded to 64.5%, a recor ...